Esperion Therapeutics ESPR Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Esperion Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Esperion Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Esperion Therapeutics's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Esperion Therapeutics's other operating expenses?
- Esperion Therapeutics (ESPR) reported other operating expenses of $86.69M in Q1 2026.
- How has Esperion Therapeutics's other operating expenses changed year-over-year?
- Esperion Therapeutics's other operating expenses decreased by 0.5% year-over-year, from $87.09M to $86.69M.
- What is the long-term trend for Esperion Therapeutics's other operating expenses?
- Over 4 years (2021 to 2025), Esperion Therapeutics's other operating expenses has grown at a 3.0% compound annual growth rate (CAGR), from $305.18M to $342.86M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.